Captivating Bortezomib: An active but still mysterious drug-Reference-Cited by-同舟云学术

Captivating Bortezomib: An active but still mysterious drug

Published:2010-04 Issue:4 Volume:34 Page:411-412
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Di Raimondo Francesco,Conticello Concetta

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference16 articles.

1. Multiple myeloma;Raab;Lancet,2009

2. Bortezomib for the treatment of mantle cell lymphoma;Kane;Clin Cancer Res,2007

3. Matondo M, Bousquet-Dubouch MP, Uttenweiler S, Recher C, Payrastre B, Manenti S, et al. Differentiation-dependent apoptosis induced by proteasome inhibitors in acute myeloid leukemia: a correlation with the proteasome status. Leuk Res.

4. Antitumor activity of bortezomib alone and in combination with TRAIL in human acute myeloid leukemia;Conticello;Acta Haematol,2008

5. Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia;Attar;Clin Cancer Res,2008

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bortezomib for the treatment of previously untreated multiple myeloma;Immunotherapy;2013-04

2. Pegylated Liposomal Doxorubicin in Salvage Chemotherapy for Multiple Myeloma Patients;Current Cancer Therapy Reviews;2013-02-01

3. Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies;International Journal of Cancer;2012-03-27

4. NF-κB localization in multiple myeloma plasma cells and mesenchymal cells;Leukemia Research;2011-01